Dasabuvir (ABT-333)

規(guī)格	庫存	目錄價(jià)	會(huì)員專享價(jià)	數(shù)量
10 mg	In-stock	￥600.00	登錄后可見	- +
25 mg	In-stock	￥980.00	登錄后可見	- +
50 mg	In-stock	￥1568.00	登錄后可見	- +

規(guī)格

庫存

目錄價(jià)

會(huì)員專享價(jià)

數(shù)量

10 mg

In-stock

￥600.00

登錄后可見

- +

25 mg

In-stock

￥980.00

登錄后可見

- +

50 mg

In-stock

￥1568.00

登錄后可見

- +

基本信息

英文名稱	Dasabuvir \| ABT-333
中文名稱	達(dá)薩布韋 \| 達(dá)塞布韋
CAS號(hào)	1132935-63-7
分子式	C26H27N3O5S
分子量	493.57
外觀	White to yellow powder
儲(chǔ)存條件	Dry, dark and at 0 - 4 ℃ for short term (days to weeks) or -20 ℃ for long term (months to years).

產(chǎn)品詳情

Dasabuvir (formerly known as ABT-333; ABT333; trade name Exviera, Viekira Pak, Viekira XR) is a nonnucleoside inhibitor of the RNA-dependent RNA polymerase encoded by the hepatitis C virus (HCV) NS5B gene. It inhibited recombinant NS5B polymerases derived from HCV genotype 1a and 1b clinical isolates, with IC50 values between 2.2 and 10.7 nM, and was at least 7,000-fold selective for the inhibition of HCV genotype 1 polymerases over human/mammalian polymerases. Dasabuvir is an FDA approved antiviral medication for the treatment of hepatitis C. It is often used together with the combination medication ombitasvir/paritaprevir/ritonavir specifically for hepatitis C virus (HCV) type 1.

相關(guān)文獻(xiàn)

抱歉，暫時(shí)沒有相關(guān)文獻(xiàn)

相關(guān)產(chǎn)品

抱歉，暫時(shí)沒有相關(guān)產(chǎn)品

瀏覽記錄

CL2455

達(dá)薩布韋 | 達(dá)塞布韋

1132935-63-7 98+% In-stock

￥600.00 10 mg

久久久无码视频,影音先锋女人av噜噜色,久久久久无码国产精品Sm高潮,人人色综合

達(dá)薩布韋 | 達(dá)塞布韋

Dasabuvir | ABT-333

化學(xué)品安全說明書(MSDS)

質(zhì)檢證書(COA)